GLI1 and cancer: These findings further support the role of the transcription factor GLI1 in the regulation of EMT and expand the repertoire of molecules including ZEB1, ZEB2, SNAI2 and TWIST [13]–[15] that act in concert with TGFβ1 and GLI1 pathways to control EMT in cancer cells.